Clinical Trial

A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This phase I study in healthy participants aims to assess the pharmacokinetics of midazolam and atorvastatin when administered alone and in combination with HRS-1301, and to assess the safety of HRS-1301 when administered alone and in combination with midazolam or atorvastatin.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-17
Trial Details
NCT Number NCT07608705
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Hyperlipidemias
Enrollment 16 participants
Start Date 2026-06-08
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-16